Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial

Authors: Aditya H. Gaur, James McCarthy, John C. Panetta, Ronald H. Dallas, John Woodford, Li Tang, Amber M. Smith, Tracy B. Stewart, Kristen Branum, Burgess B. Freeman, Nehali Patel, Elizabeth John, Stephan Chalon, Shelley Ost, Ryan N. Heine, Julie Richardson, Robbin Christensen, Patricia M. Flynn, Yvonne Van Gessel, Branko Mitasev, Jörg J. Möhrle, Fabian Gusovsky, Lidiya Bebrevska, R. Kiplin Guy - The Lancet 2020 cited by 77